Effective May 26, 2015, NuGene International, Inc. and Donna Queen executed an offer letter whereby Ms. Queen agreed to become a member of the company's Board of Directors. From May 2011 to July 2014, Ms. Queen was the President and Chief Executive Officer of Lifeline Stem Cell Skin Care, Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.012 USD | 0.00% |
|
0.00% | +0.84% |
May. 06 | Livento Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 01 | Livento Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+0.84% | 9.91M | |
+15.68% | 8.31B | |
-20.32% | 5.23B | |
-5.51% | 4.88B | |
+8.75% | 4.66B | |
+3.55% | 4B | |
+21.97% | 3.38B | |
-6.50% | 3.08B | |
-14.79% | 2.68B | |
-22.92% | 2.38B |
- Stock Market
- Equities
- NUGN Stock
- News Livento Group, Inc.
- NuGene International, Inc. Appoints Donna Queen to its Board